-
DIVERSITY IN CLINICAL TRIALS: A REVIEW OF DRUGS APPROVED BY THE FDA IN 2024
Mar 18, 2026, 21:38 PM -
PSYCHOLOGICAL AND COMPETITIVE DETERMINANTS OF LOW BACK PAIN KNOWLEDGE AMONG COMPETITIVE ROWERS
Mar 18, 2026, 21:38 PM -
DOES YOUR 1-MILLION-MEMBER COHORT TELL THE WHOLE STORY? RETHINKING ELIGIBLE POPULATION ESTIMATION IN CHRONIC DISEASE BUDGET IMPACT ANALYSES IN THE US
Mar 18, 2026, 21:38 PM -
A DESCRIPTIVE COMPARISON OF U.S. MEDICARE IRA NEGOTIATED PRICES AND AVERAGE MFN BENCHMARKS FOR PART D DRUGS
Mar 18, 2026, 21:38 PM -
PSYCHOMETRIC EVALUATION OF A NOVEL PATIENT-PROVIDER TOOL FOR ASSESSING DIABETES SELF-MANAGEMENT KNOWLEDGE AND BEHAVIOR IN ADULTS WITH TYPE 2 DIABETES MELLITUS
Mar 18, 2026, 21:38 PM -
A SYSTEMATIC REVIEW OF ONCOLYTIC VIRUSES AND GENE THERAPIES FOR RETINOBLASTOMA IN CHILDREN
Mar 18, 2026, 21:38 PM -
REAL-WORLD SYMPTOMS AND IMPACTS OF NARCOLEPSY AND IDIOPATHIC HYPERSOMNIA: QUALITATIVE RESULTS USING SOCIAL MEDIA LISTENING METHODS
Mar 18, 2026, 21:38 PM -
MODELING RARE EVENTS IN HEALTH INTERVENTION: AN APPLICATION FROM THE DEPARTMENT OF WAR DATASET
Mar 18, 2026, 21:38 PM -
YEARLY TREND OF OBESITY PREVALENCE AMONG HOSPITALIZED PATIENTS IN THE UNITED STATES: 2021-2025
Mar 18, 2026, 21:38 PM -
CLINICAL BENEFITS OF NIRMATRELVIR/RITONAVIR TREATMENT FOR COVID-19: A GLOBAL ECONOMIC VALUE SYSTEMATIC LITERATURE REVIEW
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS ANALYSIS OF RIBOCICLIB PLUS ENDOCRINE THERAPY (ET) VERSUS ABEMACICLIB PLUS ET IN THE ADJUVANT TREATMENT OF NODE POSITIVE PRE AND POSTMENOPAUSAL WOMEN WITH HR+/HER2- EARLY BREAST CANCER (EBC): A CANADIAN PAYER PERSPECTIVE
Mar 18, 2026, 21:38 PM -
COMPARING LLM-BASED TO EXPERT-CURATED EXTRACTION FOR BIOMARKER ATTRIBUTES IN LUNG AND BREAST CANCER
Mar 18, 2026, 21:38 PM -
IMPACT OF THE COVID-19 PANDEMIC ON HEALTHCARE EXPENDITURE AND RESOURCE USE IN PEOPLE LIVING WITH HIV IN THE UNITED STATES: A DIFFERENCE-IN-DIFFERENCE ANALYSIS
Mar 18, 2026, 21:38 PM -
COST-UTILITY MODEL OF MATERNAL RSV VACCINATION FROM THE PERSPECTIVE OF THE BRAZILIAN PUBLIC HEALTH SYSTEM
Mar 18, 2026, 21:38 PM -
USING EXTENDED COX MODELS WITH TIME-VARYING COVARIATES TO EXAMINE EFFECT OF VARIABLE OPIOID EXPOSURE IN CANCER RECURRENCE IN DISEASE-FREE BREAST CANCER SURVIVORS
Mar 18, 2026, 21:38 PM -
ASSOCIATION BETWEEN GLP-1 RECEPTOR AGONIST INITIATION AND ALCOHOL USE DISORDER AND ALCOHOL-RELATED MEDICAL CONDITIONS IN A U.S. ADMINISTRATIVE CLAIMS DATABASE
Mar 18, 2026, 21:38 PM -
HEALTHCARE UTILIZATION, EXPENDITURES, AND HEALTH-RELATED QUALITY OF LIFE AMONG U.S. ADULTS WITH RHEUMATOID ARTHRITIS AND COMORBID HYPERTENSION: MEDICAL EXPENDITURE PANEL SURVEY, 2020-2023
Mar 18, 2026, 21:38 PM -
CAUSAL AI IN EPIDEMIOLOGY AND HEALTHCARE: CONCEPTS AND METHODOLOGIES
Mar 18, 2026, 21:38 PM -
STRATEGIC COMPARISON OF CENTER FOR PHARMACOECONOMICS AND INSTITUTE FOR CLINICAL AND ECONOMIC REVIEW ECONOMIC EVALUATIONS
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF LOW-DOSE ATROPINE VERSUS ORTHOKERATOLOGY FOR MYOPIA CONTROL IN CHILDREN
Mar 18, 2026, 21:38 PM
